Importantly, the lack of measurable differences in HOLO-TCN2 levels suggests that these OSA patients, likely, do not have a genetic TCN2 alteration or abnormality, as previously reported in various case reports (78–81). This evidence concerns the gene TCN2 and obstructive sleep apnea syndrome.